General Information of Drug (ID: DMPBE5H)

Drug Name
6-oxo-16-formyl-estrone
Synonyms CHEMBL202432
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 312.4
Logarithm of the Partition Coefficient (xlogp) 2.9
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C19H20O4
IUPAC Name
(13S,16Z)-3-hydroxy-16-(hydroxymethylidene)-13-methyl-8,9,11,12,14,15-hexahydro-7H-cyclopenta[a]phenanthrene-6,17-dione
Canonical SMILES
C[C@]12CCC3C(C1C/C(=C/O)/C2=O)CC(=O)C4=C3C=CC(=C4)O
InChI
InChI=1S/C19H20O4/c1-19-5-4-13-12-3-2-11(21)7-15(12)17(22)8-14(13)16(19)6-10(9-20)18(19)23/h2-3,7,9,13-14,16,20-21H,4-6,8H2,1H3/b10-9-/t13?,14?,16?,19-/m0/s1
InChIKey
ZRLTUTFRAVMGPJ-SSNSBQRSSA-N
Cross-matching ID
PubChem CID
44407480
TTD ID
D02JRB

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) TTIWB6L DHB1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. J Med Chem. 2006 Feb 23;49(4):1325-45.